High blood pressure is the main risk factor for cardiovascular disease worldwide, but its control rate is unsatisfactory.
Home Blood Pressure Monitoring (HBPM) with automatic oscillometric devices and pharmaceutical care have been proposed as interventions to improve therapeutic compliance and to guide treatment decisions but their effects on BP control are still under debate.
A factorial randomized controlled clinical trial among adults undergoing drug treatment but with uncontrolled office blood pressure (140/90 mm Hg and over) and 24 hour ambulatory blood pressure monitoring (ABPM) (130/80 mmHg and over) was carried out to determine the effect of HBPM on blood pressure control.
Participants were randomly assigned to four different groups - HBPM (n=36), pharmacist care (n=35), HBPM and pharmacist care (n=32) or usual care (n=33). Medication was not changed during the trial. Blood pressure measurements were taken at 7 and 30 days after randomization, and at 60 days to assess the outcome. This was a pooled analysis of the intervention (HBPM + HBPM with pharmacist care) versus control (pharmacist care + usual care).
The results presented on June 19, 2010, at the World Congress of Cardiology (WCC) Scientific Sessions in Beijing, China shows that HBPM device reduces blood pressure and improves control.
The average of the delta, which is the difference between the Systolic and Diastolic pressure readings, for 24H systolic blood pressure differed between HBPM (8.8 ±12.9 mmHg) and control (3.4 ±11.6 mmHg) groups (p=0.018), as well as for 24h diastolic blood pressure (p=0.003). At the end of the trial 18.6 per cent of patients using HBPM compared with just 8.1 per cent of the control group had blood pressure of less than 130/80 mmHg (p=0.08)
Home Blood Pressure Monitoring device provides meaningful information to help individuals and healthcare providers evaluate the success of their healthcare initiatives.
Source:World Congress of Cardiology Press Release 6574, 19.06.2010 08:30
Automatic Blood Pressure Monitor - Model SEM-1
Recommended Selling Price: RM298.00
- Fully automatic inflation and deflation
- Fuzzy logic
- Hypertension Indicator, if systolic & diastolic is out of standard range of 135/85 mmHg
- Large display, easy to read
- Displays average of last 3 readings
- Durable fan-shaped cuff
- 21 sets memory
FREE GIFT - Omron Pencil Thermometer - Model SEM-1 For oral, rectal and underarm temperature measurement
Diabetes mellitus and hypertension are common diseases that coexist at a greater frequency than chance alone would predict.The older mum and dad gets, the greater their chance of developing high blood pressure and diabetes!
Diabetes makes high blood pressure more difficult to treat, and high blood pressure makes diabetes even more dangerous.
Hypertension in the diabetic individual markedly increases the risk and accelerates the course of cardiac disease, peripheral vascular disease, stroke, retinopathy, and nephropathy.
Call or email us for details of this and the equally attractive offer of Optium Xceed Diabetes Monitoring System.The first 20 callers will qualify for a SPECIAL DISCOUNT.
ACT NOW! Contact details on the right side of this page.
No comments:
Post a Comment